Enanta Pharmaceuticals (ENTA) Stock Chart & Stock Price History $6.56 -0.42 (-6.02%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$6.56 0.00 (-0.08%) As of 07/11/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Enanta Pharmaceuticals Stock Price Performance The Enanta Pharmaceuticals (ENTA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.00%, with a year-to-date return of 14.09%. In the past month, the stock has decreased 11.47%, reflecting recent market activity. As of the latest close, Enanta Pharmaceuticals traded at $6.56 with a market cap of $140.25 million and volume of 189,465 shares. Five years ago, the stock traded at $51.10, representing a 87.16% decrease over that period. At the time, it had a market cap of $1.02 billion and a volume of 156,400 shares. Receive ENTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-14.25%1 Month Performance-11.47%3 Month Performance+39.87%Year-To-Date Performance+14.09%1 Year Performance-59.00%5 Year Performance-87.16% ENTA Stock Chart for Saturday, July, 12, 2025 ENTA Chart by TradingView Enanta Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$6.98$6.56-6.02%$7.04$6.50189,465 shs$140.25 million07/10/2025$7.13$6.98-2.10%$7.14$6.88148,399 shs$149.23 million07/09/2025$7.75$7.13-8.00%$7.90$7.06255,062 shs$152.42 million07/08/2025$7.65$7.75+1.31%$7.93$7.56114,671 shs$165.70 million07/07/2025$7.89$7.65-3.04%$8.00$7.57100,908 shs$163.56 million07/04/2025$7.89$7.89$8.03$7.7378,004 shs$168.69 million07/03/2025$7.97$7.89-1.00%$8.03$7.7378,004 shs$168.69 million07/02/2025$7.70$7.97+3.51%$8.23$7.71209,818 shs$170.40 million07/01/2025$7.56$7.70+1.85%$7.83$7.51135,156 shs$164.63 million06/30/2025$7.50$7.56+0.80%$7.62$7.37156,827 shs$161.63 million Get the Latest News and Ratings for ENTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$7.51$7.50-0.13%$7.72$7.34234,296 shs$160.35 million06/26/2025$7.45$7.51+0.81%$7.53$7.2379,092 shs$160.56 million06/25/2025$7.32$7.45+1.78%$7.47$7.00173,629 shs$159.28 million06/24/2025$7.12$7.32+2.81%$7.42$7.00143,709 shs$156.50 million06/23/2025$7.18$7.12-0.84%$7.25$6.9584,153 shs$152.23 million06/20/2025$7.23$7.18-0.69%$7.41$6.96183,679 shs$153.51 million06/19/2025$7.23$7.23$7.34$6.8798,747 shs$154.58 million06/18/2025$7.05$7.23+2.55%$7.34$6.8798,747 shs$154.58 million06/17/2025$7.28$7.05-3.16%$7.44$7.03123,925 shs$150.71 million06/16/2025$7.50$7.28-2.93%$7.54$7.17120,413 shs$155.63 million06/13/2025$7.41$7.50+1.21%$7.87$7.16243,932 shs$160.33 million06/12/2025$7.95$7.41-6.79%$8.03$7.34278,107 shs$158.40 million06/11/2025$7.58$7.95+4.88%$8.47$7.48674,150 shs$169.95 million Related Companies AUTL Stock Chart STOK Stock Chart URGN Stock Chart PHAT Stock Chart RLAY Stock Chart ABUS Stock Chart TNGX Stock Chart CDXC Stock Chart DNTH Stock Chart MENS Stock Chart Receive ENTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.